Lavipharm (FRA:BXA0) Retained Earnings : €-23.85 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lavipharm Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Lavipharm's retained earnings for the quarter that ended in Dec. 2024 was €-23.85 Mil.

Lavipharm's quarterly retained earnings increased from Dec. 2023 (€-32.59 Mil) to Jun. 2024 (€-24.97 Mil) and increased from Jun. 2024 (€-24.97 Mil) to Dec. 2024 (€-23.85 Mil).

Lavipharm's annual retained earnings increased from Dec. 2022 (€-34.27 Mil) to Dec. 2023 (€-32.59 Mil) and increased from Dec. 2023 (€-32.59 Mil) to Dec. 2024 (€-23.85 Mil).

Lavipharm Retained Earnings Historical Data

The historical data trend for Lavipharm's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Retained Earnings Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Retained Earnings

Get a 7-Day Free Trial

-163.83

-162.11

-34.27

-32.59

-23.85

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Retained Earnings	Get a 7-Day Free Trial							-34.27	-32.24	-32.59	-24.97	-23.85

Lavipharm Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Lavipharm (FRA:BXA0) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

LAVI:Greece

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines